echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetes Care: Bariatric surgery will halve the mortality rate. Which surgery is more conducive to the cardiovascular outcome of diabetic patients?

    Diabetes Care: Bariatric surgery will halve the mortality rate. Which surgery is more conducive to the cardiovascular outcome of diabetic patients?

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diabetes (DM) is considered by the World Health Organization (WHO) as one of the four major non-communicable diseases
    .


    Currently, there are 463 million DM patients worldwide


    Diabetes mellitus (DM) is considered by the World Health Organization (WHO) as one of the four major non-communicable diseases


    Among them, China is the country with the most DM patients, with approximately 116 million patients


    Lancet This means that there is hope for curing T2DM, which is believed to require lifelong medication


    In order to further determine the two most common metabolic surgery (Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG)), which one is related to the main disadvantages of T2DM and obesity patientsHeart blood vessels to reduce events (MACE) risks associated
    .


    The recent Diabetes Care published relevant results


    Heart blood vessels

    The researchers analyzed a total of 13,490 patients, including 1,362 RYGB, 693 SG, and 11,435 T2DM and obesity matched non-surgical patients (1998-2017) who were treated at the Cleveland Clinic.
    They were followed up to December 2018
    .


    Through multivariate Cox regression analysis, the time to the occurrence of extended MACE was estimated, which was defined as the first occurrence of coronary artery event, cerebrovascular event, heart failure , kidney disease, atrial fibrillation and all-cause death


    Heart failure

    The results showed that the cumulative incidence of the primary endpoint within 5 years in the RYGB group was 13.
    7% (95% CI, 11.
    4-15.
    9), and the SG group was 24.
    7% (95% CI, 19.
    0-30.
    0), and the risk of RYGB was reduced by 23% (HR=0.
    77) ; 95%CI, 0.
    60-0.
    98)
    .


    Among the six individual endpoints, the cumulative incidence of renal disease after 5 years in RYGB was significantly lower than that of SG (2.


    The results showed that the cumulative incidence of the primary endpoint within 5 years in the RYGB group was 13.


    Compared with routine care, the incidence rate of MACE in RYGB and SG patients in 5 years

    In addition, RYGB is associated with greater reductions in body weight, glycosylated hemoglobin, and medications used to treat diabetes and cardiovascular disease
    .


    Five years after RYGB, compared with SG, patients required more upper endoscopy (45.


    In addition, RYGB is associated with greater reductions in body weight, glycosylated hemoglobin, and medications used to treat diabetes and cardiovascular disease


    In summary, among obese and T2DM patients, compared with SG, RYGB may be associated with greater weight loss, better diabetes control, and a lower risk of MACE and kidney disease


    references:

    Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care.
    Diabetes Care 2021 Sep; dc203023.
    https://doi.
    org/10.
    2337/dc20-3023

    Outcomes, in Patients With the Type Cardiovascular 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve gastrectomy, and Usual Care.
    Https://doi.
    org/10.
    2337/dc20-3023 https://doi.
    org/10.
    2337/dc20-3023 in This message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.